News

The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...
Velsera’s technology enables compliant access to sensitive datasets while keeping data within the control of its source institutions.
An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...
AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for type 1 diabetes.
Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.
A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...
LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.
Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.
The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...
Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...
EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat cerebellum.
The facility will be built to meet SFDA, FDA, EMA, and BMBL requirements and will include a fully integrated digital ...